Scalper1 News
Faced with choosing between a $10 bottle of wine and a $90 bottle of wine, which would you go for? In one experiment – with the prices of each wine clearly marked – nearly twice as many people preferred the taste of the most expensive bottle. But unknown to the volunteers, the two wines were exactly the same. This test was carried out by American researchers investigating how pricing can influence the brain’s perception of how ‘pleasant’ something is. Told it’s expensive, we tend to like it all the more. It’s an example of what behavioral scientists say is a flaw in human emotions that causes us to be overly-influenced by a good story. The read across for investors could hardly be more stark. Stories in the stock market are like a magnet. With herds of followers, these popular shares typically boast eye-catching price momentum. Yet a good proportion of them hide deteriorating fundamentals and stretched valuations that can be harder to spot (and, for some, easy to ignore). These are the market’s glamour stocks which may well be Momentum Traps – stocks where a sudden change in sentiment could see their momentum crash. Of all the dangers that investors face, perhaps none is more seductive than the siren song of stories. Stories essentially govern the way we think. We will abandon evidence in favour of a good story – James Montier Signs of a Momentum Trap Small cap stocks soared through 2013, and by early the following year some valuations looked frothy. Swept up in a wave of bullish exuberance, popular ‘blue sky’ companies like Blur ( OTC:BLURF ), Monitise ( OTC:MNQQY ) and Cloudbuy ( OTC:CDLBF ) were showing some of the classic signs of being momentum traps. As sentiment towards small caps drifted through the next 12 months, the price of each share was pummelled. The common traits shared by these and other momentum traps was that their strong price momentum hadn’t been matched by improving fundamentals. Yet, they looked expensive and their low QualityRanks pointed to firms that either weren’t profitable at all or were flagging as potentially distressed. Importantly, these were some of the most talked about small caps at the time, promoted by brokers and heavily traded by investors. They were the polar opposite of traditional ‘value’ shares but investors lapped them up all the same. In The Little Book of Behavioural Investing , James Montier of investment firm GMO, says that one of the reasons why people shy away from value investing is that value shares tend to come with poor stories. As a result, they end up being despised rather than admired. He explains: “Which would you rather own? Psychologically, we know you will feel attracted to the admired stocks. Yet the despised stocks are generally a far better investment. They significantly outperform the market as well as the admired stocks.” Indeed, evidence that momentum stocks underperform dates back to a 1993 study by three researchers who made a personal fortune from their findings. Josef Lakonishok, Andrei Shleifer and Robert Vishny showed that investors consistently overestimate future growth rates of glamour stocks relative to value stocks. They said this was because investors typically make judgement errors and extrapolate too much of the past to make predictions about the future. They proved their point by going on to run billions of dollars in their own fund management firm called LSV. Testing the performance of Momentum Traps In Stockopedia’s taxonomy of stock market winners (and losers), Momentum Traps typically have StockRanks that reflect strong momentum but poor value and quality. We can build a screen for these stocks by setting the following filters: Momentum Rank > 80 (i.e. high Momentum) QV Rank < 40 (i.e. poor combined Quality and Value) Market Cap > 100 (i.e. to focus on the more well-known shares) Top 25 stocks by Momentum Rank (i.e. 25 highest Momentum shares in the set) We’ve used the Stockopedia StockRank archives to generate the performance history of a 25 stock portfolio rebalanced annually since April 2013. The results are quite startling (click to enlarge) What happens so often with Momentum Traps is that they outperform the market dramatically… but only for a while. This strong price performance lulls investors into a false sense of security and draws in the suckers right at the wrong time. Most investors buy these stocks at the top, and suffer terrible underperformance when gravity reasserts itself. As we can see, the Momentum Trap portfolio has tracked the FTSE All Share over the last two-and-a-half years but broken everyone’s hearts in the interim. Through 2013, the Momentum Traps portfolio was very much an all-cap affair, with stocks ranging from 3i ( OTCPK:TGOPY ) to Nanoco ( OTC:NNOCF ) and Blinkx ( OTC:BLNKY ). There were (and continue to be) some stocks that held on to the momentum and did well. But in 2014, it was weighted much more heavily towards small caps. It’s here that the trouble starts. As sentiment cooled towards smaller stocks, those that were overstretched paid the heaviest price. Companies like eServGlobal, Quadrise Fuels ( OTC:QDRSF ), Johnston Press ( OTC:JHPSY ) and a handful of resources shares have continued to slide. Dodging a momentum trap bullet Using the above rules on today’s data set, we’ve compiled a list below of stocks that could see their momentum turn if investor sentiment changes. The companies include some popular names like Hutchison China MediTech (Pending: HCM ) and Optimal Payments ( OTCPK:NVAFF ). Note that the ‘buy’, ‘hold’ and ‘sell’ recommendations of the brokers that cover each company are broadly positive in their outlook. Detailed research may uncover nothing to worry about with these shares. However, QV Ranks of below 40 (out of 100) certainly warrants close attention and suggests things could be more precarious than the broker recommendations infer. Name Momentum Rank QV Rank # Buy Recs # Hold Recs # Sell Recs Admiral ( OTCPK:AMIGY ) 98 25 1 10 2 OneSavings Bank ( OTC:OSVBF ) 98 29 – 4 – Hutchison China MediTech 96 14 – – 1 Optimal Payments 95 29 4 – – Grainger ( OTC:GRGTF ) 94 10 3 4 – Severn Trent ( OTCQX:STRNY ) 94 25 2 9 1 NMC Health ( OTC:NMHLY ) 93 20 6 – – Dignity ( OTC:DGNTY ) 92 37 – 4 – To avoid the lure of stories and the risk of succumbing to momentum traps, investors should be alert when strong momentum is paired with deteriorating fundamentals or excessive valuation. Momentum is one of the strongest drivers of returns in the stock market, and certainly capable of carrying story stocks some distance. But momentum can crash, particularly in shares with heady valuations and suspect quality. It’s a message best summed up by Montier, who says the key is to focus on facts. “Focusing on the cold hard facts (soundly based in real numbers) is likely to be the best defence against the siren song of stories.” Editor’s Note: This article discusses one or more securities that do not trade on a major U.S. exchange. Please be aware of the risks associated with these stocks. Scalper1 News
Scalper1 News